Paper of the Week

Niv Marom, MD , Milan Kapadia, BS, Joseph T. Nguyen, MPH , Brittany Ammerman, MBS, Isabel Wolfe, BS, Kristin C. Halvorsen, BS, Andy O. Miller, MD, Michael W. Henry, MD , Barry D. Brause, MD, Jo A. Hannafin, MD, Robert G. Marx, MD, and Anil S. Ranawat, MDdoi: https://doi.org/10.1177/03635465221078311 Summary by Carlo Coladonato, MS Septic…

Tyler J Humphrey, BA; Alexander M Tatara, MD, PhD; Hany S Bedair, MD; Kyle Alpaugh, MD; Christopher M Melnic, MD; Sandra B Nelson, MDdoi: https://doi.org/10.1016/j.arth.2022.07.018 Summary by Nicholas F. Cozzarelli The opioid epidemic has been a significant problem in the United States, and the impactof the COVID-19 Pandemic has worsened the situation [1,2] . With…

Anderson DR, Dunbar M, Murnaghan J, et al. Aspirin or rivaroxaban for VTEprophylaxis after hip or knee arthroplasty. New England Journal of Medicine. 2018;378(8):699-707.doi: https://doi.org/10.1056/nejmoa1712746 Summary by Alexis Kasper Administration of anticoagulant prophylaxis after a total hip or knee arthroplasty hasbeen shown to reduce complications and death rates that are associated with venousthromboembolism, or VTE.1-3…

Chase C. Woodward, MD, MPH1 , Michael Eby, MD, MS1 , Rikesh Gandhi, MD1 , Stephen M. Plachta, MD1 , Keith Baldwin, MD, MPH, MPST1 , Brendan M. Holderread, MD2 , Harvey E. Smith, MD1 , Vincent Arlet, MD1 and Comron Saifi, MD1,2doi: https://doi.org/10.1177/21925682211058462 Summary by Delano Trenchfield Venous thromboemboli are well known causes of…

Preobrazhensky P, Bozhkova S, Kochish A, Tikhilov R, Kazemirsky A. Comparative analysisof pathogen structure in patients with PJI after primary total hip and knee arthroplasty.Archives of Orthopaedic and Trauma Surgery 2021 Nov; 141(11) : 1963-1969.doi: https://doi.org/10.1055/s-0033-1364102 Summary by Santiago Restrepo, BS PJI is a high concern as a front runner for causing early re-operation of…